ObjectiveTo analyze the clinical value of bronchoalveolar lavage on patients with ventilator-associated pneumonia (VAP). MethodsBronchoalveolar lavage was performed on 53 patients with VAP in our intensive care unit (ICU) from 2014 to 2017, and the clinical efficacy and related indicators were observed. ResultsA total of 53 patients were enrolled in the study, in which 4 were cured, 43 were effective, and 6 died. The total effective rate was 88.68%, and the cause of death was multiple organ failure. Pathogens were detected in the lavage fluid of 53 patients, of which 47(88.68%) were Gram-negative bacteria, 5 (9.43%) were Gram-positive bacterian and 1(1.89%)was fungal. The result of drug resistance test showed that 50 (94.3%) patients had multi-drug resistant organism infection. After treatment, the patients′ PCO2, oxygenation index, white blood cells and CRP level were significantly improved (P＜0.05), and there was no statistically significant difference in pH value and body temperature before and after treatment (P＞0.05). No patients had serious adverse reactions including malignant arrhythmia, asphyxia and massive hemoptysis. ConclusionEarly bronchoalveolar lavage treatment on patients with VAP can obtain the results of pathogenic detection more accurately, which is conducive to the correct selection of sensitive antibiotics for treatment, and the clinical treatment has significant effect and high safety.

无